1. Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK (2010) Various types and management of breast cancer: an overview. J Adv Pharm Technol Res 1(2):109–126
2. Fan C, Georgiou KR, McKinnon RA, Keefe DMK, Howe PRC, Xian CJ (2016) Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats. J Bone Miner Metab 34(3):277–290
3. Peppone LJ, Mustian KM, Rosier RN, Carroll JK, Purnell JQ, Janelsins MC et al (2014) Bone health issues in breast cancer survivors: a Medicare current beneficiary survey (MCBS) study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 22(1):245–251
4. Chen Z, Maricic M, Aragaki AK, Mouton C, Arendell L, Lopez AM et al (2009) Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative. Osteoporos Int 20(4):527–536
5. Siddiqui JA, Partridge NC (2016) Physiological bone remodeling: systemic regulation and growth factor involvement. Physiol Bethesda Md 31(3):233–245